Randomized controlled trial of fosmidomycin-clindamycin versus sulfadoxine-pyrimethamine in the treatment of Plasmodium falciparum malaria

Antimicrob Agents Chemother. 2007 May;51(5):1869-71. doi: 10.1128/AAC.01448-06. Epub 2007 Feb 26.

Abstract

Fosmidomycin-clindamycin therapy given every 12 h for 3 days was compared with a standard single oral dose of sulfadoxine-pyrimethamine. The two treatments showed comparably good tolerabilities and had an identical high degree of efficacy of 94% in a randomized trial carried out with 105 Gabonese children aged 3 to 14 years with uncomplicated malaria. These antimalarials merit further clinical exploration.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Antimalarials / therapeutic use*
  • Child
  • Child, Preschool
  • Clindamycin / administration & dosage*
  • Drug Combinations
  • Female
  • Fosfomycin / administration & dosage
  • Fosfomycin / analogs & derivatives*
  • Humans
  • Malaria, Falciparum / drug therapy*
  • Male
  • Pyrimethamine / therapeutic use*
  • Sulfadoxine / therapeutic use*

Substances

  • Antimalarials
  • Drug Combinations
  • Fosfomycin
  • fanasil, pyrimethamine drug combination
  • Clindamycin
  • fosmidomycin
  • Sulfadoxine
  • Pyrimethamine